Kramer Levin Expands IP Group with the Hiring of Pharma and Biotech Patent Litigator Christine Willgoos
For Seventh Consecutive Year, Kramer Levin is Major Sponsor of Archtober 2014
Thomas Molner’s practice focuses primarily on securities, corporate finance and business combinations. He has advised companies in connection with a broad range of transactions including public offerings for issuers and underwriters, mergers and acquisitions, leveraged buy-outs, and licensing and executive employment arrangements.Mr. Molner also regularly advises boards of directors and independent board committees of public companies on corporate governance matters.
Mr. Molner was recognized as a leading lawyer by Legal 500 US (2009-2014) and New York Super Lawyers (2009-2014).